GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (ASX:SIG) » Definitions » COGS-to-Revenue

Sigma Healthcare (ASX:SIG) COGS-to-Revenue : 0.90 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sigma Healthcare COGS-to-Revenue?

Sigma Healthcare's Cost of Goods Sold for the six months ended in Jan. 2024 was A$1,532 Mil. Its Revenue for the six months ended in Jan. 2024 was A$1,694 Mil.

Sigma Healthcare's COGS to Revenue for the six months ended in Jan. 2024 was 0.90.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sigma Healthcare's Gross Margin % for the six months ended in Jan. 2024 was 9.54%.


Sigma Healthcare COGS-to-Revenue Historical Data

The historical data trend for Sigma Healthcare's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare COGS-to-Revenue Chart

Sigma Healthcare Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.92 0.91 0.92 0.93 0.92

Sigma Healthcare Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.92 0.95 0.93 0.90

Sigma Healthcare COGS-to-Revenue Calculation

Sigma Healthcare's COGS to Revenue for the fiscal year that ended in Jan. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3103.916 / 3375.766
=0.92

Sigma Healthcare's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1532.367 / 1693.995
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sigma Healthcare  (ASX:SIG) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sigma Healthcare's Gross Margin % for the six months ended in Jan. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1532.367 / 1693.995
=9.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Sigma Healthcare COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sigma Healthcare (ASX:SIG) Business Description

Traded in Other Exchanges
Address
2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.

Sigma Healthcare (ASX:SIG) Headlines